The Effect of the 632.8 nm Laser Blood Irradiation on PASI, TC and TG in Patients with Psoriasis Vulgaris

Authors

  • Song-Guk Jo Pyongyang Medical College, KIM IL SUNG University
  • Song-Nam Ri
  • Song-Guk Jo

Abstract

Objectives: The aim of this study is to study the effect of the 632.8nm laser blood irradiation (LBI) on PASI, TC and TG in patients with psoriasis vulgaris. Patients and methods: A total of 90 cases of psoriasis vulgaris were divided into 3 groups according to the paths of laser irradiation: Intravenous Laser Blood Irradiation (ILBI: A Group), nasal mucous irradiation (B Group), no irradiation (C Group). All patients were treated by placebo with sodium bicarbonate (100mg/d) for 8 weeks while they were irradiated. Result: In all groups, the psoriasis area and severity index, total cholesterol and triglyceride decreased. Significant decreases were observed in A and B group. The psoriasis area and severity index are related with total cholesterol and triglyceride in serum. Conclusion: The 632.8nm laser blood irradiation has therapeutic effect on psoriasis vulgaris via regulating total cholesterol and triglyceride in serum.

 

Keywords: FESS, Laser blood irradiation, Intravenous laser blood irradiation, Psoriasis vulgaris.

 

Cite this Article

Ju-Song Choe, Song-Nam Ri, Song-Guk Jo. The Effect of the 632.8 nm Laser Blood Irradiation on PASI, TC and TG in Patients with Psoriasis Vulgaris. Research & Reviews: Journal of Oncology and Hematology. 2020; 9(3): 44–46p.

Downloads

Published

2021-01-13

Issue

Vol. 9 No. 3 (2020)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.